{{Infobox disease
|Name = Hepatitis
|Image = Alcoholic_hepatitis.jpg
|Caption = [[Alcoholic liver disease|Alcoholic hepatitis]] evident by fatty change, cell [[necrosis]], [[Mallory bodies]]
|ICD10 = {{ICD10|K|75|9|k|70}}
|ICD9 = {{ICD9|573.3}}
|DiseasesDB = 20061
|MedlinePlus = 001154
|eMedicineSubj =
|eMedicineTopic =
|MeshID = D006505
}}
'''Hepatitis''' (plural '''hepatitides''') is a [[medical condition]] defined by the inflammation of the [[liver]] and characterized by the presence of [[inflammation|inflammatory]] [[cell (biology)|cell]]s in the [[Tissue (biology)|tissue]] of the organ. The name is from the Greek ''hepar'' (ἧπαρ), the root being ''hepat''- (ἡπατ-), meaning ''liver'', and suffix ''-itis'', meaning "inflammation" (c. 1727).<ref>{{cite web|url=http://www.etymonline.com/index.php?search=hepatitis&searchmode=none |title=Online Etymology Dictionary |publisher=Etymonline.com |date= |accessdate=2012-08-26}}</ref> The condition can be self-limiting (healing on its own) or can progress to [[fibrosis]] (scarring) and [[cirrhosis]].

Hepatitis may occur with limited or no symptoms, but often leads to [[jaundice]], [[Anorexia (symptom)|anorexia]] (poor appetite) and [[malaise]]. Hepatitis is acute when it lasts less than six months and chronic when it persists longer. A group of [[viruses]] known as the hepatitis viruses cause most cases of hepatitis worldwide, but hepatitis can also be caused by toxic substances (notably [[Ethanol|alcohol]], certain [[medication]]s, some industrial organic solvents and plants), other [[infectious disease|infections]] and [[Autoimmunity|autoimmune]] diseases.

== Signs and symptoms ==

=== Acute ===
Initial features are of nonspecific flu-like symptoms, common to almost all acute [[viral infections]] and may include [[malaise]], [[myalgia|muscle]] and [[arthralgia|joint aches]], [[fever]], [[nausea]] or [[vomiting]], [[diarrhea]], and [[headache]]. More specific [[symptom]]s, which can be present in acute hepatitis from any cause, are: profound [[Anorexia (symptom)|loss of appetite]], aversion to [[smoking]] among [[Tobacco smoking|smokers]], [[choluria | dark urine]], [[yellowing]] of the [[Human eyes|eyes]] and [[Human skin|skin]] (i.e., [[jaundice]]) and [[Abdomen|abdominal]] discomfort. Physical findings are usually minimal, apart from [[jaundice]] in a third and tender [[hepatomegaly]] (swelling of the liver) in about 10%. Some exhibit [[lymphadenopathy]] (enlarged lymph nodes, in 5%) or [[splenomegaly]] (enlargement of the [[spleen]], in 5%).<ref>{{cite journal |author=Ryder S, Beckingham I |title=Acute hepatitis |journal=BMJ |volume=322 |issue=7279 |pages=151–153 |year=2001 |pmid = 11159575 |doi=10.1136/bmj.322.7279.151 |pmc=1119417}}</ref>

Acute viral hepatitis is more likely to be asymptomatic in younger people. Symptomatic individuals may present after convalescent stage of 7 to 10 days, with the total illness lasting 2 to 6 weeks.<ref name="bain">{{cite book |author=Bain VG, Ma M |chapter=Ch. 14: Acute Viral Hepatitis |chapterurl=http://www.gastroresource.com/GITextbook/en/Chapter14/14-4.htm |title=First principle of gastroenterology }} (an online text book)</ref>

A small proportion of people with acute hepatitis progress to [[acute liver failure]], in which the liver is unable to clear harmful substances from the circulation (leading to confusion and coma due to [[hepatic encephalopathy]]) and produce blood proteins (leading to [[peripheral oedema]] and bleeding). This may become life-threatening and occasionally requires a [[liver transplantation|liver transplant]].

=== Chronic ===
Chronic hepatitis often leads to nonspecific symptoms such as malaise, tiredness and weakness, and often leads to no symptoms at all. It is commonly identified on [[blood test]]s performed either for [[screening (medicine)|screening]] or to evaluate nonspecific symptoms. The occurrence of jaundice indicates advanced liver damage. On physical examination there may be enlargement of the liver.<ref name=MerckHome>{{MerckHome|10|137|c||Chronic hepatitis}}</ref>

Extensive damage to and scarring of liver (i.e. cirrhosis) leads to weight loss, easy bruising and bleeding tendencies, [[peripheral edema]] (swelling of the legs) and accumulation of [[ascites]] (fluid in the peritoneal cavity). Eventually, cirrhosis may lead to various complications: [[esophageal varices]] (enlarged veins in the wall of the esophagus that can cause life-threatening bleeding) [[hepatic encephalopathy]] (confusion and coma) and [[hepatorenal syndrome]] (kidney dysfunction).

[[Acne]], abnormal [[menstruation]], [[lung scarring]], inflammation of the [[thyroid gland]] and [[kidney]]s may be present in [[women]] with [[autoimmune hepatitis]].<ref name=MerckHome/>

== Diagnosis ==
Diagnosis can be made using various biochemical markers of hepatitis in conjunction with an assessment of the patient's medical history and a physical examination.

The following are biochemical markers used in the diagnosis of hepatitis:

=== Hepatitis A ===
Data taken from Harrison's Principle of Internal Medicine, 17 Edition <ref>{{cite web|url=http://www.accessmedicine.com |title= Acute Viral Hepatitis : Introduction}}</ref> 
{| class="wikitable"
|-
! Marker !! Detection Time !! Description !! Significance
|-
| Faecal HAV || 2-4 weeks || - || Early detection
|-
| Ig M anti HAV || 4-12 weeks || Enzyme immunoassay for antibodies || During Acute Illness
|-
| Ig G anti HAV || 5 weeks - persistent || Enzyme immunoassay for antobodies || Old infection or Reinfection
|}

=== Hepatitis C ===
{| class="wikitable"
|-
! Marker !! Detection Time !! Description !! Significance !! Note
|-
| HCV-RNA || 1–3 weeks || PCR || Demonstrates presence or absence of virus || Results may be intermittent during course of infection. Negative result is not indicative of absence.
|-
| anti-HCV || 5–6 weeks || Enzyme Immunoassay for antibodies || Demonstrates past or present infection || High false positive in those with autoimmune disorders and populations with low virus prevalence.
|-
| ALT || 5–6 weeks || - || Peak in ALT coincides with peak in anti-HCV || Fluctuating ALT levels is an indication of active liver disease.
|}
Data taken from the WHO website on Hepatitis C.<ref>{{cite web|url=http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index3.html#diagnostic |title=WHO &#124; Hepatitis C |publisher=Who.int |date=2010-12-08 |accessdate=2012-08-26}}</ref>

== Pathology ==

The liver, like all organs, responds to injury in a limited number of ways and a number of patterns have been identified. Liver biopsies are rarely performed for acute hepatitis and because of this the histology of chronic hepatitis is better known than that of acute hepatitis.

=== Acute ===

In acute hepatitis the lesions (areas of abnormal tissue) predominantly contain diffuse sinusoidal and portal mononuclear infiltrates ([[lymphocyte]]s, [[plasma cell]]s, [[Kupffer cell]]s) and swollen [[hepatocyte]]s. Acidophilic cells ([[Councilman body|Councilman bodies]]) are common. Hepatocyte regeneration and cholestasis (canalicular bile plugs) typically are present. Bridging hepatic [[necrosis]] (areas of necrosis connecting two or more portal tracts) may also occur. There may be some lobular disarray. Although aggregates of lymphocytes in portal zones may occur these are usually neither common nor prominent. The normal architecture is preserved. There is no evidence of [[fibrosis]] or [[cirrhosis]] (fibrosis plus regenerative nodules). In severe cases prominent hepatocellular necrosis around the central vein (zone 3) may be seen.

In submassive necrosis&nbsp;– a rare presentation of acute hepatitis&nbsp;– there is widespread hepatocellular necrosis beginning in the [[hepatic lobule|centrizonal distribution]] and progressing towards [[portal tract]]s. The degree of [[parenchymal]] inflammation is variable and is proportional to duration of [[disease]].<ref>{{cite journal |author=Boyer JL, Klatskin G |title=Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis) |journal=N. Engl. J. Med. |volume=283 |issue=20 |pages=1063–71 |year=1970 |pmid=4319402 |doi=10.1056/NEJM197011122832001}}</ref><ref name=Gimson1996>{{cite journal |author=Gimson AE |title=Fulminant and late onset hepatic failure |journal=Br J Anaesth |volume=77 |issue=1 |pages=90–8 |year=1996 |month=July |pmid=8703634 |url=http://bja.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8703634 |doi=10.1093/bja/77.1.90}}</ref> Two distinct patterns of necrosis have been recognised: (1) zonal coagulative necrosis or (2) panlobular (nonzonal) necrosis.<ref name=Kirsch2009>{{cite journal |author=Kirsch R, Yap J, Roberts EA, Cutz E |title=Clinicopathologic spectrum of massive and submassive hepatic necrosis in infants and children |journal=Hum. Pathol. |volume=40 |issue=4 |pages=516–26 |year=2009 |month=April |pmid=19121848 |doi=10.1016/j.humpath.2008.07.018 |url=http://linkinghub.elsevier.com/retrieve/pii/S0046-8177(08)00447-4}}</ref> Numerous macrophages and lymphocytes are present. Necrosis and inflammation of the biliary tree occurs.<ref name=Nakanuma1994>{{cite journal |author=Nakanuma Y, Sasaki M, Terada T, Harada K |title=Intrahepatic peribiliary glands of humans. II. Pathological spectrum |journal=J. Gastroenterol. Hepatol. |volume=9 |issue=1 |pages=80–6 |year=1994 |pmid=8155873 |doi=10.1111/j.1440-1746.1994.tb01221.x }}</ref> Hyperplasia of the surviving biliary tract cells may be present. Stromal haemorrhage is common.

The histology may show some correlation with the cause:

*Zone 1 (periportal) occurs in [[phosphorus]] poisoning or [[eclampsia]].
*Zone 2 (midzonal) – rare – is seen in [[yellow fever]].
*Zone 3 (centrilobular) occurs with ischemic injury, toxic effects, carbon tetrachloride exposure or chloroform ingestion. Drugs such as acetaminophen may be metabolized in zone 1 to toxic compounds that cause necrosis in zone 3.

Where patients have recovered from this condition, biopsies commonly show multiacinar regenerative nodules (previously known as adenomatous hyperplasia).<ref name=Wanless1995>{{cite journal |author=Wanless IR |title=Terminology of nodular hepatocellular lesions |journal=Hepatology |volume=22 |issue=3 |pages=983–993 |date=September 1995 |doi=10.1002/hep.1840220341 |url=http://onlinelibrary.wiley.com/doi/10.1002/hep.1840220341/abstract |pmid=7657307}}</ref>

Massive hepatic necrosis is also known and is usually rapidly fatal. The pathology resembles that of submassive necrosis but is more markered in both degree and extent.

=== Chronic ===

Chronic hepatitis has been better studied and several conditions have been described.

Chronic hepatitis with piecemeal (periportal) necrosis (or interface hepatitis) with or without fibrosis.<ref name=Gastroenterology1994>{{cite journal |author=Gastroenterology IWPotWCo |title=Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994 |journal=Am. J. Gastroenterol. |volume=89 |issue=8 Suppl |pages=S177–81 |year=1994 |month=August |pmid=8048409 }}</ref> (formerly chronic active hepatitis) is any case of hepatitis occurring for more than 6 months with portal based inflammation, fibrosis, disruption of the terminal plate, and piecemeal necrosis. This term has now been replaced by the diagnosis of 'chronic hepatitis 

Chronic hepatitis without piecemeal necrosis (or interface hepatitis)<ref name=Gastroenterology1994/> (formerly called chronic persistent hepatitis) is chronic hepatitis with no significant periportal necrosis or regeneration with a fairly dense mononuclear portal infiltrate. Councilman bodies are frequently seen within the lobule. 

Chronic hepatitis without piecemeal necrosis (or interface hepatitis)<ref name=Gastroenterology1994/> (formerly called chronic lobular hepatitis) is chronic hepatitis with persistent parenchymal focal hepatocyte necrosis ([[apoptosis]]) with mononuclear sinusoidal infiltrates. 

The older terms have been [[deprecate]]d because the conditions are now understood as being able to alter over time so that what might have been regarded as a relatively benign lesion could still progress to cirrhosis. The simpler term ''chronic hepatitis'' is now preferred in association with the causative agent (when known) and a grade based on the degree of inflammation, piecemeal or bridging necrosis (interface hepatitis) and the stage of fibrosis. Several grading systems have been proposed but none have been adopted universally.

Cirrhosis is a diffuse process characterized by regenerative nodules that are separated from one another by bands of fibrosis. It is the end stage for many chronic liver diseases. The pathophysiological process that results in cirrhosis is as follows: hepatocytes are lost through a gradual process of hepatocellular injury and inflammation. This injury stimulates a regenerative response in the remaining hepatocytes. The fibrotic scars limit the extent to which the normal architecture can be reestablished as the scars isolate groups of hepatocytes. This results in nodules formation. Angiogenisis (new vessel formation) accompanies scar production which results in the formation of abnormal channels between the central hepatic veins and the portal vessels. This in turn causes shunting of blood around the regenerating parenchyma. Normal vascular structures including the sinusoidal channels may be obliterated by fibrotic tissue leading to portal hypertension. The overall reduction in hepatocyte mass, in conjunction with the portal blood shunting, prevents the liver from accomplishing its usual functions – the filtering of blood from the gastrointestinal tract and serum protein production. These changes give rise to the clinical manifestations of cirrhosis.

=== Specific cases ===

Most of the causes of hepatitis cannot be distinguished on the basis of the pathology but some do have particular features that are suggestive of a particular diagnosis.

The presence of micronodular cirrhosis, [[Mallory_body|Mallory bodies]] and fatty change within a single biopsy are highly suggestive of alcoholic injury.<ref name=Baptista1981>{{cite journal |title=Alcoholic liver disease: morphological manifestations. Review by an international group |journal=Lancet |volume=1 |issue=8222 |pages=707–11 |year=1981 |month=March |pmid=6110925 }}</ref> Perivenular, pericellular fibrosis (known as 'chicken wire fibrosis' because of its appearance on [[trichrome]] or [[van Gieson stain]]s) with partial or complete obliteration of the central vein is also very suggestive of alcohol abuse.

Cardiac, ischemic and venous outflow obstruction all cause similar patterns.<ref name=Arcidi1981>{{cite journal |author=Arcidi JM, Moore GW, Hutchins GM |title=Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy |journal=Am. J. Pathol. |volume=104 |issue=2 |pages=159–66 |year=1981 |month=August |pmid=6455066 |pmc=1903755 }}</ref> The sinusoids are often dilated and filled with erythrocytes. The liver cell plates may be compressed. [[Coagulative necrosis]] of the hepatocytes can occur around the central vein. [[Hemosiderin]] and lipochrome laden [[macrophage]]s and inflammatory cells may be found. At the edge of the fibrotic zone cholestasis may be present. The portal tracts are rarely significantly involved until late in the course.

Biliary tract disease including [[primary biliary cirrhosis]], [[sclerosing cholangitis]], inflammatory changes associated with idiopathic [[inflammatory bowel disease]] and duct obstruction have similar histology in their early stages. Although these diseases tend to primarily involve the biliary tract they may also be associated with chronic inflammation within the liver and difficult to distinguish on histological grounds alone. The fibrotic changes associated with these disease principally involve the portal tracts with cholangiole proliferation, portal tract inflammation with [[neutrophil]]s surrounding the cholangioles, disruption of the terminal plate by mononuclear inflammatory cells and occasional hepatocyte necrosis. The central veins are either not involved in the fibrotic process or become involved only late in the course of the disease. Consequently the central–portal relationships are minimally distorted. Where cirrhosis is present it tends to be in the form of a portal–portal bridging fibrosis.

Hepatitis E causes different histological patterns that depend on the host's background.<ref name=Selves2010>{{cite journal |author=Selves J, Kamar N, Mansuy JM, Péron JM |title=[Hepatitis E virus: A new entity] |language=French |journal=Ann Pathol |volume=30 |issue=6 |pages=432–8 |year=2010 |month=December |pmid=21167429 |doi=10.1016/j.annpat.2010.10.003 |url=http://www.masson.fr/masson/S0242-6498(10)00317-2}}</ref> In immunocompetent patients the typical pattern is of severe intralobular necrosis and acute cholangitis in the portal tract with numerous neutrophils. This normally resolves without sequelae. Disease is more severe in those with preexisting liver disease such as cirrhosis. In the immunocompromised patients chronic infection may result with rapid progression to cirrhosis. The histology is similar to that found in hepatitis C virus with dense lymphocytic portal infiltrate, constant piecemeal necrosis and fibrosis.

== Causes ==
{{columns-list|colwidth=30em|

=== Acute ===
*[[Viral hepatitis]] (15 families)
**[[Adenoviridae]]: [[Adenoviruses]]
**[[Arenavirus]]es: [[Guanarito virus]],<ref name=Miguet1990>{{cite journal |author=Miguet JP, Coaquette A, Bresson-Hadni S, Lab M |title=[The other types of viral hepatitis] |language=French |journal=Rev Prat |volume=40 |issue=18 |pages=1656–9 |year=1990 |month=June |pmid=2164704 }}</ref> [[Junín virus]],<ref name="Miguet1990" /> [[Lassa fever virus]],<ref name="Miguet1990" /> [[Lujo virus]],<ref name=Briese2009>{{cite journal |author=Briese T, Paweska JT, McMullan LK, ''et al.'' |title=Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa |journal=PLoS Pathog. |volume=5 |issue=5 |pages=e1000455 |year=2009 |month=May |pmid=19478873 |pmc=2680969 |doi=10.1371/journal.ppat.1000455 |url=http://dx.plos.org/10.1371/journal.ppat.1000455 |editor1-last=Buchmeier |editor1-first=Michael J}}</ref> [[Machupo virus]]<ref name="Miguet1990" /> and [[Sabiá virus]]<ref name="Miguet1990" />
**[[Bunyavirus]]es: [[Crimean-Congo hemorrhagic fever virus]],<ref name=Appannanavar2011>{{cite journal |author=Appannanavar SB, Mishra B |title=An update on crimean congo hemorrhagic Fever |journal=J Glob Infect Dis |volume=3 |issue=3 |pages=285–92 |year=2011 |month=July |pmid=21887063 |pmc=3162818 |doi=10.4103/0974-777X.83537 |url=http://www.jgid.org/article.asp?issn=0974-777X;year=2011;volume=3;issue=3;spage=285;epage=292;aulast=Appannanavar}}</ref> [[Dobrava virus]],<ref name=Peters2002>{{cite journal |author=Peters W |title=Novel and challenging infections of man. A brief overview |journal=Parassitologia |volume=44 |issue=1–2 |pages=33–42 |year=2002 |month=June |pmid=12404808 }}</ref> [[Hantaan virus]],<ref name=Glass1994>{{cite journal |author=Glass GE, Watson AJ, LeDuc JW, Childs JE |title=Domestic cases of hemorrhagic fever with renal syndrome in the United States |journal=Nephron |volume=68 |issue=1 |pages=48–51 |year=1994 |pmid=7991040 |doi=10.1159/000188086 }}</ref> [[Puumala virus]],<ref name=Olsson2010>{{cite journal |author=Olsson GE, Leirs H, Henttonen H |title=Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? |journal=Vector Borne Zoonotic Dis. |volume=10 |issue=6 |pages=549–61 |year=2010 |month=August |pmid=20795916 |doi=10.1089/vbz.2009.0138 }}</ref> [[Rift Valley fever virus]],<ref name=Ikegami2011>{{cite journal |author=Ikegami T, Makino S |title=The pathogenesis of Rift Valley fever |journal=Viruses |volume=3 |issue=5 |pages=493–519 |year=2011 |month=May |pmid=21666766 |pmc=3111045 |doi=10.3390/v3050493 }}</ref> [[Seoul virus]]<ref name=Burke2011>{{cite journal |author=Burke RL, Kronmann KC, Daniels CC, ''et al.'' |title=A Review of Zoonotic Disease Surveillance Supported by the Armed Forces Health Surveillance Center |journal=Zoonoses Public Health |year=2011 |month=November |pmid=22128834 |doi=10.1111/j.1863-2378.2011.01440.x |volume=59 |issue=3 |pages=164–75}}</ref> and [[SFTS virus]]<ref name = "Xue-jie Yu et al.">Fever with thrombocytopenia associated with a novel Bunyavirus in China. N Engl J Med. 2011 Mar 16. [http://www.nejm.org/doi/full/10.1056/NEJMoa1010095#t=article Full text]</ref>
**[[Coronaviridae]]: [[SARS coronavirus|Severe acute respiratory syndrome virus]]<ref name=Weiss2011>{{cite journal |author=Weiss SR, Leibowitz JL |title=Coronavirus pathogenesis |journal=Adv. Virus Res. |volume=81 |pages=85–164 |year=2011 |pmid=22094080 |doi=10.1016/B978-0-12-385885-6.00009-2 |url=http://linkinghub.elsevier.com/retrieve/pii/B978-0-12-385885-6.00009-2 |series=Advances in Virus Research |isbn=9780123858856}}</ref>
**[[Erythrovirus]]: [[Parvovirus B19]]<ref name="pmid9606764">{{cite journal |author=Naides SJ |title=Rheumatic manifestations of parvovirus B19 infection |journal=Rheum. Dis. Clin. North Am. |volume=24 |issue=2 |pages=375–401 |year=1998 |month=May |pmid=9606764 |doi=10.1016/S0889-857X(05)70014-4}}</ref>
**[[Flavivirus]]es: [[Akhurma virus]],<ref name=Charrel2003>{{cite journal |author=Charrel RN, de Lamballerie X |title=[The Alkhurma virus (family Flaviviridae, genus Flavivirus): an emerging pathogen responsible for hemorrhage fever in the Middle East] |language=French |journal=Med Trop (Mars) |volume=63 |issue=3 |pages=296–9 |year=2003 |pmid=14579470 }}</ref> [[Dengue]],<ref name=Ramos-De2011>{{cite journal |author=Ramos-De La Medina A, Remes-Troche JM, González-Medina MF, ''et al.'' |title=[Abdominal and gastrointestinal symptoms of Dengue fever. Analysis of a cohort of 8559 patients] |language=Spanish; Castilian |journal=Gastroenterol Hepatol |volume=34 |issue=4 |pages=243–7 |year=2011 |month=April |pmid=21474206 |doi=10.1016/j.gastrohep.2011.01.012 |url=http://www.elsevier.es/en/linksolver/ft/pii/S0210-5705(11)00125-7}}</ref> [[Hepatitis C]], [[Kyasanur Forest disease|Kyasanur Forest disease virus]],<ref name=Gritsun2003>{{cite journal |author=Gritsun TS, Nuttall PA, Gould EA |title=Tick-borne flaviviruses |journal=Adv. Virus Res. |volume=61 |pages=317–71 |year=2003 |pmid=14714436 |doi=10.1016/S0065-3527(03)61008-0 |series=Advances in Virus Research |isbn=0120398613 }}</ref> [[Omsk hemorrhagic fever|Omsk hemorrhagic fever virus]],<ref name="Gritsun2003" /> [[Yellow fever]]
**[[Filovirus]]es: [[Ebola virus]] and [[Marburg virus]]<ref name=Tandon1987>{{cite journal |author=Tandon BN, Acharya SK |title=Viral diseases involving the liver |journal=Baillieres Clin. Gastroenterol. |volume=1 |issue=2 |pages=211–30 |year=1987 |month=April |pmid=2822180 |doi=10.1016/0950-3528(87)90002-9 }}</ref>
**[[Hepadnaviridae]]: [[Hepatitis B]]
**[[Hepeviridae]]: [[Hepatitis E]]
**[[Herpesvirus]]es: [[Cytomegalovirus]],<ref name=Xiong2010>{{cite journal |author=Xiong W |title=[Clinical efficacy of treating infant cytomegalovirus hepatitis with ganciclovir and impact on cytokines] |language=Chinese |journal=Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |volume=26 |issue=11 |pages=1130–2 |year=2010 |month=November |pmid=21322282 }}</ref> [[Epstein Barr virus]],<ref name=Okano2011>{{cite journal |author=Okano M, Gross TG |title=Acute or Chronic Life-Threatening Diseases Associated With Epstein-Barr Virus Infection |journal=Am. J. Med. Sci. |year=2011 |month=November |pmid=22104426 |doi=10.1097/MAJ.0b013e318236e02d |volume=343 |issue=6 |pages=483–9}}</ref> [[Varicella zoster virus]], [[Human herpesvirus 6]], [[Human herpesvirus 7]] and [[Human herpesvirus 8]]<ref name=GallegosOrozco2010>{{cite journal |author=Gallegos-Orozco JF, Rakela-Brödner J |title=Hepatitis viruses: not always what it seems to be |journal=Rev Med Chil |volume=138 |issue=10 |pages=1302–11 |year=2010 |month=October |pmid=21279280 |doi= 10.4067/S0034-98872010001100016|url=http://www.scielo.cl/cgi-bin/fbpe/fbtext?pid=S0034-98872010001100016&lng=en&nrm=iso&tlng=en}}</ref>
**[[Orthomyxovirus]]es: [[Influenza]]<ref name=Papic2011>{{cite journal |author=Papic N, Pangercic A, Vargovic M, Barsic B, Vince A, Kuzman I |title=Liver involvement during influenza infection: perspective on the 2009 influenza pandemic |journal=Influenza Other Respi Viruses |year=2011 |month=September |pmid=21951624 |doi=10.1111/j.1750-2659.2011.00287.x |volume=6 |issue=3 |pages=e2–5}}</ref>
**[[Parvoviridae]]: [[Parvovirus B19]]<ref name="pmid9606764"/>
**[[Picornavirus]]es: [[Echovirus]],<ref name=Bondarenko1992>{{cite journal |author=Bondarenko VI, Zadorozhnaia VI |title=[The role of enteroviruses in the etiology of diseases of the pancreas, kidneys and liver] |language=Russian |journal=Lik. Sprava |issue=3 |pages=58–62 |year=1992 |month=March |pmid=1329355 }}</ref> [[Hepatitis A]]
**[[Reovirus]]: [[Colorado tick fever|Colorado tick fever virus]],<ref name=Zaidi2002>{{cite journal |author=Zaidi SA, Singer C |title=Gastrointestinal and hepatic manifestations of tickborne diseases in the United States |journal=Clin. Infect. Dis. |volume=34 |issue=9 |pages=1206–12 |year=2002 |month=May |pmid=11941547 |doi=10.1086/339871 |url=http://www.cid.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11941547}}</ref> [[Reovirus 3]]<ref name=Organ1998>{{cite journal |author=Organ EL, Rubin DH |title=Pathogenesis of reovirus gastrointestinal and hepatobiliary disease |journal=Curr. Top. Microbiol. Immunol. |volume=233 |issue=Pt 2 |pages=67–83 |year=1998 |pmid=9599932 |doi=10.1007/978-3-642-72095-6_4 |series=Current Topics in Microbiology and Immunology |isbn=978-3-642-72097-0 }}</ref>
**Unassigned family: [[Hepatitis D]]

*Bacterial
**''[[Anaplasma]]''<ref name=Heyman2010>{{cite journal |author=Heyman P, Cochez C, Hofhuis A, ''et al.'' |title=A clear and present danger: tick-borne diseases in Europe |journal=Expert Rev Anti Infect Ther |volume=8 |issue=1 |pages=33–50 |year=2010 |month=January |pmid=20014900 |doi=10.1586/eri.09.118 |url=http://www.future-drugs.com/doi/abs/10.1586/eri.09.118?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed}}</ref>
**''[[Babesia]]''<ref name="Siński2011">{{cite journal |author=Siński E, Welc-Faleciak R, Pogłód R |title=Babesia spp. infections transmitted through blood transfusion |journal=Wiad Parazytol |volume=57 |issue=2 |pages=77–81 |year=2011 |pmid=21682090 }}</ref>
**''[[Bartonella]]''<ref name=Massei2005>{{cite journal |author=Massei F, Gori L, Macchia P, Maggiore G |title=The expanded spectrum of bartonellosis in children |journal=Infect. Dis. Clin. North Am. |volume=19 |issue=3 |pages=691–711 |year=2005 |month=September |pmid=16102656 |doi=10.1016/j.idc.2005.06.001 |url=http://linkinghub.elsevier.com/retrieve/pii/S0891-5520(05)00064-4}}</ref>
**''[[Chlamydia trachomatis]]''<ref name=Yang2008>{{cite journal |author=Yang HW, Jung SH, Han HY, ''et al.'' |title=[Clinical feature of Fitz-Hugh-Curtis syndrome: analysis of 25 cases] |language=Korean |journal=Korean J Hepatol |volume=14 |issue=2 |pages=178–84 |year=2008 |month=June |pmid=18617765 |doi=10.3350/kjhep.2008.14.2.178 |url=http://www.koreanjhepatol.org/journal/view.php?year=2008&vol=14&no=2&spage=178}}</ref>
**''[[Coxiella burnetii]]''<ref>{{cite book |chapter=Figure 7.12 (Some causes of acute parenchymal damage) |editor=Parveen, M.D. Kumar, Michael, M.D. Clark |title=Clinical Medicine |publisher=W.B. Saunders |location=Philadelphia, PA |year=2005 |isbn=0-7020-2763-4 }}</ref>
**''[[Ehrlichia]]''<ref name=Blanco2002>{{cite journal |author=Blanco JR, Oteo JA |title=Human granulocytic ehrlichiosis in Europe |journal=Clin. Microbiol. Infect. |volume=8 |issue=12 |pages=763–72 |year=2002 |month=December |pmid=12519349 |url=http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1198-743X&date=2002&volume=8&issue=12&spage=763 |doi=10.1046/j.1469-0691.2002.00557.x}}</ref>
**''[[Leptospira]]''
**''[[Listeria]]''<ref name=Scholing2007>{{cite journal |author=Scholing M, Schneeberger PM, van den Dries P, Drenth JP |title=Clinical features of liver involvement in adult patients with listeriosis. Review of the literature |journal=Infection |volume=35 |issue=4 |pages=212–8 |year=2007 |month=June |pmid=17646920 |doi=10.1007/s15010-007-6006-2 }}</ref>
**''[[Mycobacterium tuberculosis]]''<ref name=Drebber2008>{{cite journal |author=Drebber U, Kasper HU, Ratering J, ''et al.'' |title=Hepatic granulomas: histological and molecular pathological approach to differential diagnosis--a study of 442 cases |journal=Liver Int. |volume=28 |issue=6 |pages=828–34 |year=2008 |month=July |pmid=18312287 |doi=10.1111/j.1478-3231.2008.01695.x }}</ref>
**''[[Nocardia]]''<ref name=Raby1990>{{cite journal |author=Raby N, Forbes G, Williams R |title=Nocardia infection in patients with liver transplants or chronic liver disease: radiologic findings |journal=Radiology |volume=174 |issue=3 Pt 1 |pages=713–6 |year=1990 |month=March |pmid=2406779 |url=http://radiology.rsnajnls.org/cgi/pmidlookup?view=long&pmid=2406779}}</ref>
**''[[Novosphingobium aromaticivorans]]''<ref name=Mohammed2009>{{cite journal |author=Mohammed JP, Mattner J |title=Autoimmune disease triggered by infection with alphaproteobacteria |journal=Expert Rev Clin Immunol |volume=5 |issue=4 |pages=369–379 |year=2009 |month=July |pmid=20161124 |pmc=2742979 |doi=10.1586/ECI.09.23 }}</ref><ref name=Kaplan2004>{{cite journal |author=Kaplan MM |title=Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis |journal=Am. J. Gastroenterol. |volume=99 |issue=11 |pages=2147–9 |year=2004 |month=November |pmid=15554995 |doi=10.1111/j.1572-0241.2004.41121.x }}</ref><ref name=Selmi2004>{{cite journal |author=Selmi C, Gershwin ME |title=Bacteria and human autoimmunity: the case of primary biliary cirrhosis |journal=Curr Opin Rheumatol |volume=16 |issue=4 |pages=406–10 |year=2004 |month=July |pmid=15201604 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1040-8711&volume=16&issue=4&spage=406 |doi=10.1097/01.bor.0000130538.76808.c2}}</ref><ref name=Selmi2003>{{cite journal |author=Selmi C, Balkwill DL, Invernizzi P, ''et al.'' |title=Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium |journal=Hepatology |volume=38 |issue=5 |pages=1250–7 |year=2003 |month=November |pmid=14578864 |doi=10.1053/jhep.2003.50446 }}</ref>
**''[[Orientia tsutsugamushi]]''<ref name=Yen2003>{{cite journal |author=Yen TH, Chang CT, Lin JL, Jiang JR, Lee KF |title=Scrub typhus: a frequently overlooked cause of acute renal failure |journal=Ren Fail |volume=25 |issue=3 |pages=397–410 |year=2003 |month=May |pmid=12803503 |doi=10.1081/JDI-120021152 }}</ref><ref name=Park2003>{{cite journal |author=Park JI, Han SH, Cho SC, ''et al.'' |title=[Outbreak of hepatitis by Orientia tsutsugamushi in the early years of the new millenium] |language=Korean |journal=Taehan Kan Hakhoe Chi |volume=9 |issue=3 |pages=198–204 |year=2003 |month=September |pmid=14515037 |url=http://www.koreanjhepatol.org/journal/view.php?year=2003&vol=9&no=3&spage=198}}</ref><ref name=Bernabeu-Wittel2005>{{cite journal |author=Bernabeu-Wittel M, Segura-Porta F |title=[Rickettsioses] |language=Spanish; Castilian |journal=Enferm. Infecc. Microbiol. Clin. |volume=23 |issue=3 |pages=163–72 |year=2005 |month=March |pmid=15757589 |url=http://www.elsevier.es/en/linksolver/ft/ivp/0213-005X/23/163 |doi=10.1157/13072167}}</ref>
**''[[Rickettsia]]''<ref name="Bernabeu-Wittel2005" />
**''[[Rhodococcus]]''<ref name=Brown2003>{{cite book |author=Brown JM, McNeil MM |chapter=''Nocardia'', ''Rhodococcus'', ''Gordonia'', ''Actinomadura'', ''Streptomyces'', and other aerobic actinomycetes |editor=Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH |title=Manual of clinical microbiology |publisher=American Society for Microbiology |location=Washington DC |year=2003 |pages=502–531 |edition=8th}}</ref>
**''[[Salmonella]]''<ref name=Connor2005)>{{cite journal |author=Connor BA, Schwartz E |title=Typhoid and paratyphoid fever in travellers |journal=Lancet Infect Dis |volume=5 |issue=10 |pages=623–8 |year=2005 |month=October |pmid=16183516 |doi=10.1016/S1473-3099(05)70239-5 |url=http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(05)70239-5}}</ref>
**''[[Streptococcus pyogenes]]''<ref>{{cite journal | author = Elishkewitz K, Shapiro R, Amir J, Nussinovitch M | year = | title = Hepatitis in scarlet fever | url = | journal = Isr Med Assoc J | volume = 6 | issue = 9| pages = 569–570 }}</ref>
**''[[Treponema pallidum]]<ref name=Cook1997>{{cite journal |author=Cook GC |title=Liver involvement in systemic infection |journal=Eur J Gastroenterol Hepatol |volume=9 |issue=12 |pages=1239–47 |year=1997 |month=December |pmid=9471032 }}</ref>
**''[[Yersinia]]''<ref name=Bottone1997>{{cite journal |author=Bottone EJ |title=Yersinia enterocolitica: the charisma continues |journal=Clin. Microbiol. Rev. |volume=10 |issue=2 |pages=257–76 |year=1997 |month=April |pmid=9105754 |pmc=172919 |url=http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=9105754}}</ref>

*Protozoal
**''[[Entamoeba histolytica]]''<ref name=Seitz1995>{{cite journal |author=Seitz HM |title=[Parasitic diseases of the liver] |language=German |journal=Verh Dtsch Ges Pathol |volume=79 |pages=241–8 |year=1995 |pmid=8600687 }}</ref>
**''[[Cryptosporidium]]<ref name=Chen2002>{{cite journal |author=Chen XM, LaRusso NF |title=Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy |journal=Semin. Liver Dis. |volume=22 |issue=3 |pages=277–89 |year=2002 |month=August |pmid=12360421 |doi=10.1055/s-2002-34505 |url=http://www.thieme-connect.com/DOI/DOI?10.1055/s-2002-34505}}</ref>
**''[[Isospora]]''<ref name=Michiels1994>{{cite journal |author=Michiels JF, Hofman P, Bernard E, ''et al.'' |title=Intestinal and extraintestinal Isospora belli infection in an AIDS patient. A second case report |journal=Pathol. Res. Pract. |volume=190 |issue=11 |pages=1089–93; discussion 1094 |year=1994 |month=November |pmid=7746744 |doi=10.1016/S0344-0338(11)80908-8 }}</ref><ref name=Walther2009>{{cite journal |author=Walther Z, Topazian MD |title=Isospora cholangiopathy: case study with histologic characterization and molecular confirmation |journal=Hum. Pathol. |volume=40 |issue=9 |pages=1342–6 |year=2009 |month=September |pmid=19447468 |doi=10.1016/j.humpath.2009.01.020 |url=http://linkinghub.elsevier.com/retrieve/pii/S0046-8177(09)00076-8}}</ref>
**''[[Leishmania]]''<ref name="Seitz1995" />
**''[[Plasmodium]]''<ref name=Anand2005>{{cite journal |author=Anand AC, Puri P |title=Jaundice in malaria |journal=J. Gastroenterol. Hepatol. |volume=20 |issue=9 |pages=1322–32 |year=2005 |month=September |pmid=16105116 |doi=10.1111/j.1440-1746.2005.03884.x |url=http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0815-9319&date=2005&volume=20&issue=9&spage=1322}}</ref>
**''[[Toxoplasma]]''

*Parasitic
**''[[Ascaris lumbricoides]]''<ref name="Seitz1995" />
**''[[Ancylostoma]]''<ref name=Miller1979>{{cite journal |author=Miller TA |title=Hookworm infection in man |journal=Adv. Parasitol. |volume=17 |pages=315–84 |year=1979 |pmid=395835 |doi=10.1016/S0065-308X(08)60552-7 |series=Advances in Parasitology |isbn=9780120317172 }}</ref>
**''[[Baylisascaris]]''<ref name=Gavin2005>{{cite journal |author=Gavin PJ, Kazacos KR, Shulman ST |title=Baylisascariasis |journal=Clin. Microbiol. Rev. |volume=18 |issue=4 |pages=703–18 |year=2005 |month=October |pmid=16223954 |pmc=1265913 |doi=10.1128/CMR.18.4.703-718.2005 |url=http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=16223954}}</ref>
**''[[Capillaria hepatica]]''<ref name=Li2010>{{cite journal |author=Li CD, Yang HL, Wang Y |title=Capillaria hepatica in China |journal=World J. Gastroenterol. |volume=16 |issue=6 |pages=698–702 |year=2010 |month=February |pmid=20135717 |pmc=2817057 |url=http://www.wjgnet.com/1007-9327/full/v16/i6/698.htm |doi=10.3748/wjg.v16.i6.698}}</ref>
**''[[Clonorchis sinensis]]''<ref name="Seitz1995" />
**''[[Dicrocoelium dendriticum]]''<ref name=Pokora2001>{{cite journal |author=Pokora Z |title=[Role of gastropods in epidemiology of human parasitic diseases] |language=Polish |journal=Wiad Parazytol |volume=47 |issue=1 |pages=3–24 |year=2001 |pmid=16888946 }}</ref>
**''[[Echinococcus]]''<ref name="Seitz1995" />
**''[[Fasciola hepatica]]''<ref name="Seitz1995" />
**''[[Fasciolopsis buski]]''<ref name=Garcia2007>{{cite journal |author=Garcia HH, Moro PL, Schantz PM |title=Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis |journal=Curr. Opin. Infect. Dis. |volume=20 |issue=5 |pages=489–94 |year=2007 |month=October |pmid=17762782 |doi=10.1097/QCO.0b013e3282a95e39 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0951-7375&volume=20&issue=5&spage=489}}</ref>
**''[[Metorchis]]''<ref name=Mordvinov2012>{{cite journal |author=Mordvinov VA, Yurlova NI, Ogorodova LM, Katokhin AV |title=Opisthorchis felineus and Metorchis bilis are the main agents of liver fluke infection of humans in Russia |journal=Parasitol. Int. |volume=61 |issue=1 |pages=25–31 |year=2012 |month=March |pmid=21840415 |doi=10.1016/j.parint.2011.07.021 |url=http://linkinghub.elsevier.com/retrieve/pii/S1383-5769(11)00119-X}}</ref>
**''[[Necator (nematode)|Necator]]''<ref name="Miller1979" />
**''[[Opisthorchis]]''<ref name="Seitz1995" />
**''[[Paragonimus]]''<ref name=Singcharoen1988>{{cite journal |author=Singcharoen T, Rawd-Aree P, Baddeley H |title=Computed tomography findings in disseminated paragonimiasis |journal=Br J Radiol |volume=61 |issue=721 |pages=83–6 |year=1988 |month=January |pmid=3349245 |doi=10.1259/0007-1285-61-721-83 }}</ref>
**''[[Strongyloides stercoralis]]''<ref name=Soroczan1996>{{cite journal |author=Soroczan W |title=[Strongyloidosis. II. Clinical manifestations] |language=Polish |journal=Wiad Parazytol |volume=42 |issue=3 |pages=291–312 |year=1996 |pmid=9012132 }}</ref>
**''[[Schistosoma]]''<ref name=Fried2011>{{cite journal |author=Fried B, Reddy A, Mayer D |title=Helminths in human carcinogenesis |journal=Cancer Lett. |volume=305 |issue=2 |pages=239–49 |year=2011 |month=June |pmid=20667649 |doi=10.1016/j.canlet.2010.07.008 |url=http://linkinghub.elsevier.com/retrieve/pii/S0304-3835(10)00345-9}}</ref>
**''[[Toxocara]]''<ref name=Ishibashi1995>{{cite journal |author=Ishibashi H, Tsuchiya Y |title=[Hepatic toxocariasis] |language=Japanese |journal=Ryoikibetsu Shokogun Shirizu |issue=7 |pages=48–50 |year=1995 |pmid=8749411 }}</ref>

*[[Fungus|Fungal]]
**''[[Aspergillus]]''<ref name=Nikeghbalian2009>{{cite journal |author=Nikeghbalian S, Salahi R, Salahi H, ''et al.'' |title=Hepatic abscesses after liver transplant: 1997-2008 |journal=Exp Clin Transplant |volume=7 |issue=4 |pages=256–60 |year=2009 |month=December |pmid=20353378 |url=http://www.ectrx.org/forms/ectrxcontentshow.php?year=2009&volume=7&issue=4&supplement=0&makale_no=0&spage_number=256&content_type=FULL%20TEXT}}</ref>
**''[[Candida (fungus)|Candida]]''<ref name=Romero2011>{{cite journal |author=Romero FA, Razonable RR |title=Infections in liver transplant recipients |journal=World J Hepatol |volume=3 |issue=4 |pages=83–92 |year=2011 |month=April |pmid=21603030 |pmc=3098392 |doi=10.4254/wjh.v3.i4.83 |url=http://www.wjgnet.com/1948-5182/full/v3/i4/83.htm}}</ref>
**''[[Cryptococcus (fungus)|Cryptococcus]]''<ref name=Li2010>{{cite journal |author=Li SS, Mody CH |title=Cryptococcus |journal=Proc Am Thorac Soc |volume=7 |issue=3 |pages=186–96 |year=2010 |month=May |pmid=20463247 |doi=10.1513/pats.200907-063AL |url=http://pats.atsjournals.org/cgi/pmidlookup?view=long&pmid=20463247}}</ref>
**''[[Histoplasma]]''<ref name=Aidé2009>{{cite journal |author=Aidé MA |title=Chapter 4—histoplasmosis |journal=J Bras Pneumol |volume=35 |issue=11 |pages=1145–51 |year=2009 |month=November |pmid=20011851 |url=http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132009001100013&lng=en&nrm=iso&tlng=en |doi=10.1590/S1806-37132009001100013}}</ref>
**''[[Microsporidium]]''<ref name=Chukwuma1996>{{cite journal |author=Chukwuma C |title=Microsporidium in AIDS patients: a perspective |journal=East Afr Med J |volume=73 |issue=1 |pages=72–5 |year=1996 |month=January |pmid=8625869 }}</ref><ref name=Arcay2001>{{cite journal |author=Arcay L |title=[Human microsporidiosis] |language=Spanish; Castilian |journal=Invest Clin |volume=42 |issue=Suppl 1|pages=3–42 |year=2001 |month=May |pmid=11416983 }}</ref><ref name=Atías1995>{{cite journal |author=Atías A |title=[Update on microsporidiosis in humans] |language=Spanish; Castilian |journal=Rev Med Chil |volume=123 |issue=6 |pages=762–72 |year=1995 |month=June |pmid=8525232 }}</ref>
*[[Algae|Algal]]
**''[[Prototheca]]''<ref name=Chan1990>{{cite journal |author=Chan JC, Jeffers LJ, Gould EW, ''et al.'' |title=Visceral protothecosis mimicking sclerosing cholangitis in an immunocompetent host: successful antifungal therapy |journal=Rev. Infect. Dis. |volume=12 |issue=5 |pages=802–7 |year=1990 |pmid=2237120 |doi=10.1093/clinids/12.5.802 }}</ref><ref name=Narita2008>{{cite journal |author=Narita M, Muder RR, Cacciarelli TV, Singh N |title=Protothecosis after liver transplantation |journal=Liver Transpl. |volume=14 |issue=8 |pages=1211–5 |year=2008 |month=August |pmid=18668655 |doi=10.1002/lt.21565 }}</ref>

{{Unreferenced section|date=December 2011}}
*Non infectious
**[[Alcohol]]<ref name=alcomayo >{{cite web|url=http://www.mayoclinic.com/health/alcoholic-hepatitis/DS00785|title=Alcoholic hepatitis|publisher=Mayo Clinic}}</ref>
**[[Autoimmunity|Auto immune]] conditions: [[Lupus erythematosus|systemic lupus erythematosus]]<ref name=lupushep >{{cite doi|10.1136/bcr-2013-008591|noedit}}</ref>
**[[Drugs]]: [[Paracetamol]], [[amoxycillin]], [[tuberculosis treatment|antituberculosis medicines]], [[minocycline]] and many others ([[Hepatitis#Drug induced|see longer list below]]).
**[[Ischemic hepatitis]] ([[circulatory]] insufficiency)
**[[Metabolic diseases]]: [[Wilson's disease]]<ref name=wilson >{{cite web|url=http://www.wilsonsdisease.org/about-wilsondisease.php|title=About Wilson Disease|publisher=Wilson Disease Association}}</ref>
**[[Pregnancy]]
** [[Toxin]]s: [[Amanita]] toxin in [[mushroom]]s, [[carbon tetrachloride]], [[asafetida]]

=== Chronic ===

*[[Alcohol]]<ref name=alcomayo />
*[[Autoimmune]]
**[[Autoimmune hepatitis]]
*[[Drugs]]
**[[Isoniazid]]
**[[Ketoconazole]]
**[[Methyldopa]]
**[[Nitrofurantoin]]
* [[Heredity|Inherited]]
**[[Wilson's disease]]<ref name=wilson />
**[[Alpha 1-antitrypsin deficiency]]
*[[Non-alcoholic steatohepatitis]]
*[[Viral hepatitis]]:  ([[Hepatitis A]] does not cause chronic hepatitis)
**[[Hepatitis B]] with or without [[hepatitis D]]
**[[Hepatitis C]] 
**[[Hepatitis E]]<ref name=deNiet>{{cite journal | author = de Niet A, Zaaijer HL, Ten Berge I, Weegink CJ, Reesink HW, Beuers U | year = 2012 | title = Chronic hepatitis E after solid organ transplantation | url = | journal = Neth J Med | volume = 70 | issue = 6| pages = 261–266 }}</ref>
}}

===Notes===

*[[Primary biliary cirrhosis]] and [[primary sclerosing cholangitis]] occasionally mimic chronic hepatitis<ref name="bain"/>

== Discussion ==

=== Alcoholic hepatitis ===

{{Main|Alcoholic hepatitis}}

[[Ethanol]], mostly in [[alcoholic beverage]]s, is a significant cause of hepatitis. Usually [[alcoholic hepatitis]] comes after a period of increased [[alcoholic beverage|alcohol consumption]]. Alcoholic hepatitis is characterized by a variable constellation of symptoms, which may include feeling unwell, enlargement of the liver, development of fluid in the [[abdomen]] [[ascites]], and modest elevation of liver blood tests. Alcoholic hepatitis can vary from mild with only liver test elevation to severe liver inflammation with development of jaundice, prolonged [[prothrombin time]], and [[liver failure]]. Severe cases are characterized by either [[obtundation]] (dulled consciousness) or the combination of elevated [[bilirubin]] levels and prolonged [[prothrombin time]]; the mortality rate in both categories is 50% within 30 days of onset.

Alcoholic hepatitis is distinct from [[cirrhosis]] caused by long-term alcohol consumption. Alcoholic hepatitis can occur in patients with chronic [[alcoholic liver disease]] and alcoholic cirrhosis. Alcoholic hepatitis by itself does not lead to cirrhosis, but cirrhosis is more common in patients with long-term alcohol consumption. Patients who drink alcohol to excess are also more often than others found to have hepatitis C.{{Citation needed|date=April 2008}} The combination of hepatitis C and alcohol consumption accelerates the development of cirrhosis.

=== Drug-induced ===
{{Main|Hepatotoxicity}}

A large number of drugs can cause hepatitis:<ref>{{cite web
| url = http://www.healthatoz.com/healthatoz/Atoz/dc/caz/infc/hepa/hepres.jsp
| title = Hepatitis as a result of chemicals and drugs
| accessdate = 2006-07-01
| work = HealthAtoZ
|archiveurl = http://web.archive.org/web/20060623141402/http://www.healthatoz.com/healthatoz/Atoz/dc/caz/infc/hepa/hepres.jsp <!-- Bot retrieved archive --> |archivedate = 2006-06-23}}</ref>
* [[Agomelatine]] ([[antidepressant]])
* [[Allopurinol]]
* [[Amitriptyline]] ([[antidepressant]])
* [[Amiodarone]] ([[Antiarrhythmic agent|antiarrhythmic]])
* [[Atomoxetine]] <ref>{{cite journal |author=Lim JR, Faught PR, Chalasani NP, Molleston JP |title=Severe liver injury after initiating therapy with atomoxetine in two children |journal=J. Pediatr. |volume=148 |issue=6 |pages=831–4 |year=2006 |pmid=16769398 |doi=10.1016/j.jpeds.2006.01.035 }}</ref>
*[[Azathioprine]]<ref>{{cite journal | author = Bastida G, Nos P, Aguas M, Beltrán B, Rubín A, Dasí F, Ponce J | title = Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease | journal = Aliment Pharmacol Ther | volume = 22 | issue = 9 | pages = 775–82 | year = 2005
| pmid = 16225485 | doi = 10.1111/j.1365-2036.2005.02636.x
}}</ref>
* [[Halothane]] (a specific type of [[Inhalational anaesthetic|anesthetic gas]])
* [[Hormonal contraception|Hormonal contraceptives]]
* [[Ibuprofen]] and [[indomethacin]] ([[NSAID]]s)
* [[Isoniazid]] (INH), [[rifampicin]], and [[pyrazinamide]] ([[tuberculosis]]-specific [[antibiotic]]s)
* [[Ketoconazole]] ([[Antifungal medication|antifungal]])
* [[Loratadine]] ([[antihistamine]])
* [[Methotrexate]] ([[Immunosuppressant|immune suppressant]])
* [[Methyldopa]] ([[antihypertensive]])
* [[Minocycline]] ([[tetracycline antibiotic]])
* [[Nifedipine]] ([[antihypertensive]])
* [[Nitrofurantoin]] ([[antibiotic]])
* [[Paracetamol]] ([[acetaminophen]] in the [[United States]]) can cause hepatitis when taken in an [[overdose]]. The severity of [[liver damage]] may be limited by prompt administration of [[acetylcysteine]].
* [[Phenytoin]] and [[valproic acid]] ([[Anticonvulsant|antiepileptics]])
* [[Troglitazone]] ([[Anti-diabetic drug|antidiabetic]], withdrawn in 2000 for causing hepatitis)
* [[Zidovudine]] ([[Antiretroviral drug|antiretroviral]] i.e., against [[HIV]])
* Some herbs and [[Dietary supplement|nutritional supplements]]<ref name="pmid11151906">{{cite journal |author=Nadir A, Reddy D, Van Thiel DH |title=Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity |journal=Am. J. Gastroenterol. |volume=95 |issue=12 |pages=3634–7 |year=2000 |pmid=11151906| doi = 10.1111/j.1572-0241.2000.03386.x}}</ref>

The clinical course of drug-induced hepatitis is quite variable, depending on the drug and the patient's tendency to react to the drug. For example, [[halothane]] hepatitis can range from mild to fatal as can [[Isoniazid|INH]]-induced hepatitis. [[Hormonal contraception]] can cause structural changes in the liver. [[Amiodarone]] hepatitis can be untreatable since the long [[half life]] of the drug (up to 60 days) means that there is no effective way to stop exposure to the drug. [[Statin]]s can cause elevations of [[liver function]] [[blood tests]] normally without indicating an underlying hepatitis. Lastly, human variability is such that any drug can be a cause of hepatitis.

=== Other toxic substances ===

Other toxic substances can cause hepatitis. Examples include:
* [[Amatoxin]]-containing [[mushroom]]s, including the [[Death Cap]] (''Amanita phalloides''), the [[Destroying angel|Destroying Angel]] (''Amanita ocreata''), and some species of ''Galerina''. A portion of a single [[mushroom]] can be enough to be lethal (10&nbsp;mg or less of α-amanitin).
* White [[phosphorus]], an industrial toxin and war chemical.
* All [[chlorinated hydrocarbon]]s (i.e. [[Carbon tetrachloride]], [[chloroform]], and [[trichloroethylene]]) can cause [[steatohepatitis]] (hepatitis with [[fatty liver]]).
* [[Cylindrospermopsin]], a [[toxin]] from the [[cyanobacterium]] ''Cylindrospermopsis raciborskii'' and other [[cyanobacteria]].

=== Metabolic disorders ===

Some metabolic disorders cause different forms of hepatitis. [[Hemochromatosis]] (due to [[iron]] accumulation) and [[Wilson's disease]] ([[copper]] accumulation) can cause liver inflammation and [[necrosis]].

[[Non-alcoholic steatohepatitis]] (NASH) is effectively a consequence of [[metabolic syndrome]].

=== Obstructive ===

Obstructive jaundice is jaundice occurring due to obstruction of the [[bile duct]] (by [[gallstone]]s or external obstruction by [[cancer]]). If longstanding, it leads to destruction and inflammation of liver tissue.

=== Autoimmune ===

Anomalous presentation of [[human leukocyte antigen]] (HLA) class II on the surface of [[hepatocyte]]s, possibly due to [[gene]]tic predisposition or acute liver infection; causes a cell-mediated [[immune response]] against the body's own liver, resulting in autoimmune hepatitis.

=== Alpha 1-antitrypsin deficiency ===

In severe cases of [[alpha 1-antitrypsin deficiency]] (A1AD), the accumulated [[protein]] in the [[endoplasmic reticulum]] causes [[liver cell damage]] and [[inflammation]].

=== Non-alcoholic fatty liver disease ===

[[Non-alcoholic fatty liver disease]] (NAFLD) is the occurrence of [[fatty liver]] in people who have no history of alcohol use. It is most commonly associated with [[obesity]] (80% of all obese people have fatty liver). It is more common in women. Severe NAFLD leads to inflammation, a state referred to as ''non-alcoholic steatohepatitis'' (NASH), which on biopsy of the liver resembles alcoholic hepatitis (with fat droplets and [[Inflammation|inflammatory]] cells, but usually no [[Mallory body|Mallory bodies]]).

The diagnosis depends on [[medical history]], [[Physical examination|physical exam]], [[blood test]]s, [[radiology|radiological]] [[Medical imaging|imaging]] and sometimes a [[liver biopsy]]. The initial evaluation to identify the presence of fatty infiltration of the liver is [[medical imaging]], including such [[Medical ultrasonography|ultrasound]], [[computed tomography]] (CT), or [[Magnetic resonance imaging|magnetic resonance]] (MRI). However, imaging cannot readily identify inflammation in the liver. Therefore, the differentiation between steatosis and NASH often requires a liver biopsy. It can also be difficult to distinguish NASH from [[alcoholic hepatitis]] when the patient has a history of alcohol consumption. Sometimes in such cases a trial of abstinence from alcohol along with follow-up blood tests and a repeated liver biopsy are required.

NASH is becoming recognized as the most important cause of liver disease second only to hepatitis C in numbers of patients going on to [[cirrhosis]].{{Citation needed|date=April 2008}}

=== Ischemic hepatitis ===
{{Main|Ischemic hepatitis}}

Ischemic hepatitis is caused by decreased circulation to the liver cells. Usually this is due to decreased blood pressure (or [[Shock (circulatory)|shock]]), leading to the equivalent term "shock liver." [[Patients]] with ischemic hepatitis are usually very ill due to the underlying cause of [[Shock (circulatory)|shock]]. Rarely, ischemic hepatitis can be caused by local problems with the [[blood vessels]] that supply [[oxygen]] to the liver (such as [[thrombosis]], or [[clotting]] of the [[hepatic artery]] which partially supplies [[blood]] to [[liver cells]]). [[Blood testing]] of a person with ischemic hepatitis will show very high levels of [[liver function tests|transaminase]] [[enzymes]] ([[Aspartate transaminase|AST]] and [[Alanine transaminase|ALT]]), which may exceed 1000 U/L. The elevation in these [[blood tests]] is usually transient (lasting 7 to 10 days). It is rare that [[liver function]] will be affected by ischemic hepatitis.

=== Giant cell hepatitis ===
	
Giant cell hepatitis is a rare form of hepatitis (~100 cases reported) that predominantly occurs in children. Diagnosis is made on the basis of the presence of hepatocellular multinucleate giant cells.<ref name=Kirsch2009/><ref name=Torbenson2010>{{cite journal |author=Torbenson M, Hart J, Westerhoff M, ''et al.'' |title=Neonatal giant cell hepatitis: histological and etiological findings |journal=Am. J. Surg. Pathol. |volume=34 |issue=10 |pages=1498–503 |year=2010 |month=October |pmid=20871223 |doi=10.1097/PAS.0b013e3181f069ab |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=34&issue=10&spage=1498}}</ref><ref name=Krokhina2010>{{cite journal |author=Krokhina NB, Ushakova RA, Kobeleva IaM |title=[Significance of hepatic biopsy specimens in the diagnosis of liver disease in babies of the first year of life] |language=Russian |journal=Arkh. Patol. |volume=72 |issue=1 |pages=19–23 |year=2010 |pmid=20369579 }}</ref> Cases presenting in adults are rare and tend to be rapidly progressive.<ref name=Hayashi2011>{{cite journal |author=Hayashi H, Narita R, Hiura M, ''et al.'' |title=A case of adult autoimmune hepatitis with histological features of giant cell hepatitis |journal=Intern. Med. |volume=50 |issue=4 |pages=315–9 |year=2011 |pmid=21325763 |url=http://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/50.4063?from=PubMed |doi=10.2169/internalmedicine.50.4063}}</ref><ref name=Hartl2010>{{cite journal |author=Hartl J, Buettner R, Rockmann F, ''et al.'' |title=Giant cell hepatitis: an unusual cause of fulminant liver failure |journal=Z Gastroenterol |volume=48 |issue=11 |pages=1293–6 |year=2010 |month=November |pmid=21043007 |doi=10.1055/s-0029-1245476 |url=http://www.thieme-connect.com/DOI/DOI?10.1055/s-0029-1245476}}</ref><ref name=Gábor1997>{{cite journal |author=Gábor L, Pál K, Zsuzsa S |title=Giant cell hepatitis in adults |journal=Pathol. Oncol. Res. |volume=3 |issue=3 |pages=215–8 |year=1997 |month=September |pmid=18470733 |doi=10.1007/BF02899924 |url=http://por.hu/1997/3/3/0215/0215a.pdf}}</ref><ref name=Alexopoulou2003>{{cite journal |author=Alexopoulou A, Deutsch M, Ageletopoulou J, ''et al.'' |title=A fatal case of postinfantile giant cell hepatitis in a patient with chronic lymphocytic leukaemia |journal=Eur J Gastroenterol Hepatol |volume=15 |issue=5 |pages=551–5 |year=2003 |month=May |pmid=12702915 |doi=10.1097/01.meg.0000050026.34359.7c |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0954-691X&volume=15&issue=5&spage=551}}</ref><ref name=Bianchi1994>{{cite journal |author=Bianchi L, Terracciano LM |title=[Giant cell hepatitis in adults] |language=German |journal=Praxis (Bern 1994) |volume=83 |issue=44 |pages=1237–41 |year=1994 |month=November |pmid=7973279 }}</ref> The cause is currently unknown but an infectious cause is suspected.<ref name="pmid15615251">{{cite journal |author=Duhaut P, Bosshard S, Ducroix JP |title=Is giant cell arteritis an infectious disease? Biological and epidemiological evidence |journal=Presse Médicale (Paris, France : 1983) |volume=33 |issue=19 Pt 2 |pages=1403–8 |year=2004 |month=November |pmid=15615251 |doi=10.1016/S0755-4982(04)98939-7}}</ref><ref name=Shet1998>{{cite journal |author=Shet TM, Kandalkar BM, Vora IM |title=Neonatal hepatitis--an autopsy study of 14 cases |journal=Indian J Pathol Microbiol |volume=41 |issue=1 |pages=77–84 |year=1998 |month=January |pmid=9581081 }}</ref> The condition tends to improve with the use of [[ribivirin]] suggesting a viral origin.<ref name=Hassoun2000>{{cite journal |author=Hassoun Z, N'Guyen B, Cote J, ''et al.'' |title=A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin |journal=Can. J. Gastroenterol. |volume=14 |issue=8 |pages=729–31 |year=2000 |month=September |pmid=11185540 |url=http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=2&atlKy=5390&isuKy=200&isArt=t}}</ref><ref name=Durand1997>{{cite journal |author=Durand F, Degott C, Sauvanet A, ''et al.'' |title=Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin |journal=J. Hepatol. |volume=26 |issue=3 |pages=722–6 |year=1997 |month=March |pmid=9075682 |doi=10.1016/S0168-8278(97)80440-0}}</ref> Hepatitis E,<ref name="pmid17410455">{{cite journal |author=Harmanci O, Onal IK, Ersoy O, Gürel B, Sökmensüer C, Bayraktar Y |title=Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies |journal=Digestive Diseases and Sciences |volume=52 |issue=12 |pages=3521–3 |year=2007 |month=December |pmid=17410455 |doi=10.1007/s10620-006-9698-8}}</ref> hepatitis C,<ref name="pmid16949926">{{cite journal |author=Moreno A, Moreno A, Pérez-Elías MJ, Quereda C, Fernández-Muñoz R, Antela A, Moreno L, Bárcena R, López-San Román A, Celma ML, García-Martos M, Moreno S |title=Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature |journal=Human Pathology |volume=37 |issue=10 |pages=1344–9 |year=2006 |month=October |pmid=16949926 |doi=10.1016/j.humpath.2006.05.003 }}</ref> paramyxovirus,<ref name=Fimmel1993>{{cite journal |author=Fimmel CJ, Guo L, Compans RW, ''et al.'' |title=A case of syncytial giant cell hepatitis with features of a paramyxoviral infection |journal=Am. J. Gastroenterol. |volume=93 |issue=10 |pages=1931–7 |year=1998 |month=October |pmid=9772058 |doi=10.1111/j.1572-0241.1998.00548.x }}</ref><ref name=Krech1998>{{cite journal |author=Krech RH, Geenen V, Maschek H, Högemann B |title=[Adult giant cell hepatitis with fatal outcome. Clinicopathologic case report and reflections on pathogenesis] |language=German |journal=Pathologe |volume=19 |issue=3 |pages=221–5 |year=1998 |month=May |pmid=9648148 |url=http://link.springer.de/link/service/journals/00292/bibs/8019003/80190221.htm |doi=10.1007/s002920050277}}</ref><ref name=Koff1991>{{cite journal |author=Koff RS |title=Acute and chronic giant cell hepatitis: a paramyxovirus infection? |journal=Gastroenterology |volume=101 |issue=3 |pages=863–4 |year=1991 |month=September |pmid=1860651 }}</ref><ref name=Phillips1991>{{cite journal |author=Phillips MJ, Blendis LM, Poucell S, ''et al.'' |title=Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features |journal=N. Engl. J. Med. |volume=324 |issue=7 |pages=455–60 |year=1991 |month=February |pmid=1988831 |doi=10.1056/NEJM199102143240705 }}</ref> papillomavirus<ref name=Drut1998>{{cite journal |author=Drut R, Gómez MA, Drut RM, Cueto RE, Lojo M |title=[Human papillomavirus, neonatal giant cell hepatitis and biliary duct atresia] |language=Spanish; Castilian |journal=Acta Gastroenterol. Latinoam. |volume=28 |issue=1 |pages=27–31 |year=1998 |pmid=9607071 }}</ref><ref name=Drut1996>{{cite journal |author=Drut R, Gómez MA, Drut RM, Lojo MM |title=Human papillomavirus (HPV)-associated neonatal giant cell hepatitis (NGCH) |journal=Pediatr Pathol Lab Med |volume=16 |issue=3 |pages=403–12 |year=1996 |pmid=9025842 }}</ref> and Human herpes virus 6<ref name=Potenza2008>{{cite journal |author=Potenza L, Luppi M, Barozzi P, ''et al.'' |title=HHV-6A in syncytial giant-cell hepatitis |journal=N. Engl. J. Med. |volume=359 |issue=6 |pages=593–602 |year=2008 |month=August |pmid=18687640 |doi=10.1056/NEJMoa074479 }}</ref><ref name=Kuntzen2005>{{cite journal |author=Kuntzen T, Friedrichs N, Fischer HP, Eis-Hübinger AM, Sauerbruch T, Spengler U |title=Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse drug reaction |journal=Eur J Gastroenterol Hepatol |volume=17 |issue=10 |pages=1131–4 |year=2005 |month=October |pmid=16148562 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0954-691X&volume=17&issue=10&spage=1131 |doi=10.1097/00042737-200510000-00020}}</ref> have been suggested as causes. A similar condition has been reported in cats but it is not known if there is any connection between these conditions.<ref name=Suzuki2001>{{cite journal |author=Suzuki K, Nakayama H, Doi K |title=Giant cell hepatitis in two young cats |journal=J. Vet. Med. Sci. |volume=63 |issue=2 |pages=199–201 |year=2001 |month=February |pmid=11258461 |url=http://joi.jlc.jst.go.jp/JST.JSTAGE/jvms/63.199?lang=en&from=PubMed |doi=10.1292/jvms.63.199}}</ref>

== See also ==
* [[Hepatocellular carcinoma]]
* [[World Hepatitis Day]]

== References ==
{{Reflist|30em}}

== External links ==
* [http://www.who.int/topics/hepatitis/en/ WHO fact sheet of hepatitis]
* [http://www.cdc.gov/ncidod/diseases/hepatitis/ Viral Hepatitis at the Centers for Disease Control]
{{Gastroenterology}}
{{Inflammation}}

[[Category:Hepatitis| ]]
[[Category:Inflammations]]
[[Category:Healthcare-associated infections]]